Jubilant Cadista Pharmaceuticals is recalling 11,412 cartons of Drospirenone and Ethinyl Estradiol tablets (3 mg/0.02 mg), which is a generic birth control medication. This recall involves 34,236 blister cards because the tablets failed quality testing for dissolution at the 3-month stability point, meaning they may not break down properly in the body. If the medication does not dissolve as designed, the body may not absorb the necessary hormones, which could result in the product being less effective at preventing pregnancy. This recall affects generic versions of Yaz distributed nationwide.
The failure of the tablets to dissolve correctly means the active hormones may not reach the required levels in a patient's system. This defect poses a significant risk of unintended pregnancy for consumers relying on this medication for contraception.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.